Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).
Cook, M. A. & Wright, G. D. The past, present, and future of antibiotics. Sci. Transl. Med. 14, eabo7793 (2022).
Bugg, T. D. H., Braddick, D., Dowson, C. G. & Roper, D. I. Bacterial cell wall assembly: still an attractive antibacterial target. Trends Biotechnol. 29, 167–173 (2011).
Lovering, A. L., Safadi, S. S. & Strynadka, N. C. J. Structural perspective of peptidoglycan biosynthesis and assembly. Annu. Rev. Biochem. 81, 451–478 (2012).
Theuretzbacher, U., Blasco, B., Duffey, M. & Piddock, L. J. V. Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections. Nat. Rev. Drug Discov. 22, 957–975 (2023).
Sham, L.-T. et al. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science 345, 220–222 (2014).
Chamakura, K. R. et al. A viral protein antibiotic inhibits lipid II flippase activity. Nat. Microbiol. 2, 1480–1484 (2017).
Adler, B. A. et al. Multicopy suppressor screens reveal convergent evolution of single-gene lysis proteins. Nat. Chem. Biol. 19, 759–766 (2023).
Kuk, A. C. Y., Hao, A. & Lee, S.-Y. Structure and mechanism of the lipid flippase MurJ. Annu. Rev. Biochem. 91, 705–729 (2022).
Kumar, S., Mollo, A., Kahne, D. & Ruiz, N. The bacterial cell wall: from lipid II flipping to polymerization. Chem. Rev. 122, 8884–8910 (2022).
Kumar, S., Rubino, F. A., Mendoza, A. G. & Ruiz, N. The bacterial lipid II flippase MurJ functions by an alternating-access mechanism. J. Biol. Chem. 294, 981–990 (2019).
Kuk, A. C. Y., Mashalidis, E. H. & Lee, S.-Y. Crystal structure of the MOP flippase MurJ in an inward-facing conformation. Nat. Struct. Mol. Biol. 24, 171–176 (2017).
Zheng, S. et al. Structure and mutagenic analysis of the lipid II flippase MurJ from Escherichia coli. Proc. Natl Acad. Sci. USA 115, 201802192 (2018).
Kuk, A. C. Y., Hao, A., Guan, Z. & Lee, S.-Y. Visualizing conformation transitions of the lipid II flippase MurJ. Nat. Commun. 10, 1736 (2019).
Mott, J. E. et al. Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis. J. Antimicrob. Chemother. 62, 720–729 (2008).
Huber, J. et al. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus. Chem. Biol. 16, 837–848 (2009).
Chu, J. et al. Discovery of MRSA active antibiotics using primary sequence from the human microbiome. Nat. Chem. Biol. 12, 1004–1006 (2016).
Chu, J. et al. Human microbiome inspired antibiotics with improved β-lactam synergy against MDR Staphylococcus aureus. ACS Infect. Dis. 4, 33–38 (2018).
Bernhardt, T. G., Wang, I.-N., Struck, D. K. & Young, R. Breaking free: ‘protein antibiotics’ and phage lysis. Res. Microbiol. 153, 493–501 (2002).
Cahill, J. & Young, R. Phage lysis: multiple genes for multiple barriers. Adv. Virus Res. 103, 33–70 (2019).
Chamakura, K. & Young, R. Phage single-gene lysis: finding the weak spot in the bacterial cell wall. J. Biol. Chem. 294, 3350–3358 (2019).
Chamakura, K. R. & Young, R. Single-gene lysis in the metagenomic era. Curr. Opin. Microbiol. 56, 109–117 (2020).
Orta, A. K. et al. The mechanism of the phage-encoded protein antibiotic from ΦX174. Science 381, eadg9091 (2023).
Chamakura, K. R. et al. Rapid de novo evolution of lysis genes in single-stranded RNA phages. Nat. Commun. 11, 6009 (2020).
Shi, M. et al. Redefining the invertebrate RNA virosphere. Nature 540, 539–543 (2016).
Rumnieks, J. & Tars, K. Diversity of pili-specific bacteriophages: genome sequence of IncM plasmid-dependent RNA phage M. BMC Microbiol. 12, 277–277 (2012).
Bolla, J. R. et al. Direct observation of the influence of cardiolipin and antibiotics on lipid II binding to MurJ. Nat. Chem. 10, 363–371 (2018).
Mukherjee, S. et al. Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins. Nat. Commun. 11, 1598 (2020).
Ereño-Orbea, J. et al. Structural basis of enhanced crystallizability induced by a molecular chaperone for antibody antigen-binding fragments. J. Mol. Biol. 430, 322–336 (2018).
Olsthoorn, R. C. L., Garde, G., Dayhuff, T., Atkins, J. F. & Van Duin, J. Nucleotide sequence of a single-stranded RNA phage from Pseudomonas aeruginosa: kinship to coliphages and conservation of regulatory RNA structures. Virology 206, 611–625 (1995).
Meeske, A. J. et al. MurJ and a novel lipid II flippase are required for cell wall biogenesis in Bacillus subtilis. Proc. Natl Acad. Sci. USA 112, 6437–6442 (2015).
Butler, E. K., Davis, R. M., Bari, V., Nicholson, P. A. & Ruiz, N. Structure–function analysis of MurJ reveals a solvent-exposed cavity containing residues essential for peptidoglycan biogenesis in Escherichia coli. J. Bacteriol. 195, 4639–4649 (2013).
Butler, E. K., Tan, W. B., Joseph, H. & Ruiz, N. Charge requirements of lipid II flippase activity in Escherichia coli. J. Bacteriol. 196, 4111–4119 (2014).
Rubino, F. A. et al. Detection of transport intermediates in the peptidoglycan flippase MurJ identifies residues essential for conformational cycling. J. Am. Chem. Soc. 142, 5482–5486 (2020).
Kohga, H. et al. Crystal structure of the lipid flippase MurJ in a ‘squeezed’ form distinct from its inward- and outward-facing forms. Structure 30, 1088–1097 (2022).
WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance (World Health Organization, 2024).
Teague, S. J. Implications of protein flexibility for drug discovery. Nat. Rev. Drug Discov. 2, 527–541 (2003).
Simmons, K. J., Chopra, I. & Fishwick, C. W. G. Structure-based discovery of antibacterial drugs. Nat. Rev. Microbiol. 8, 501–510 (2010).
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
Sham, L., Zheng, S., Yakhnina, A. A., Kruse, A. C. & Bernhardt, T. G. Loss of specificity variants of WzxC suggest that substrate recognition is coupled with transporter opening in MOP-family flippases. Mol. Microbiol. 109, 633–641 (2018).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
Bernhardt, T. G. & De Boer, P. A. J. The Escherichia coli amidase AmiC is a periplasmic septal ring component exported via the twin-arginine transport pathway. Mol. Microbiol. 48, 1171–1182 (2003).
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
Pei, J., Kim, B.-H. & Grishin, N. V. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res. 36, 2295–2300 (2008).